Security

SRB Company is committed to the regenerative medicine industry and has chosen to collaborate with reputable international enterprises. We will partner with Indonesian medical institutions and universities to conduct clinical and efficacy trials. In the future, we aim to continue advancing biotechnology research and development to address medical technology challenges in Indonesia and provide the latest medical options for its people. SRB Company has invited Dr. Alex, an expert in lung disease prevention and treatment during the COVID-19 period, as an advisor. We have also signed an MOU with Rumah Sakit Penyakit Infeksi Prof. Dr. Sulianti Saroso, the largest public hospital in Indonesia, for a clinical trial on "Exosome Therapy for Post-Tuberculosis Fibrosis." This will be Indonesia's first clinical research project on exosomes.